Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...

Since the approval of Luxturna, there has been a wave of gene therapies advancing in clinical trials to treat genetic vision ...

On the occasion of its deal with Cure51, find out about NVIDIA's biotech strategy as it gets more and more involved in the ...

The companies Pathos AI, Taysha Gene Therapies, and Abeona Therapeutics bagged the biggest biotech funding rounds overall in ...

Delve into what the new CRISPR tool, CAST, has to offer. CRISPR-associated transposases are already gaining traction in ...

Discover how biotechs and big pharma are developing novel treatments for high cholesterol with a range of different targets.

We’re nearly halfway through 2025, and like clockwork, the American Society of Clinical Oncology (ASCO) annual summit took place from the 30th of May to the 3rd of June in Chicago this year. With ...

In April, the major pharma giants in the mergers and acquisitions (M&As) space were Novartis and Merck. Last month, however, the big names that announced multimillion-dollar buyouts were GSK, Sanofi, ...